ASPERGILLUS NIGER .ALPHA.-GALACTOSIDASE
UNII 6215K8E2M8

Substance Identification & Data

This profile provides standardized clinical and technical data for Aspergillus Niger .alpha.-galactosidase, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 6215K8E2M8.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 9025-35-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

6215K8E2M8

CAS Registry Number

9025-35-8

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ASPERGILLUS NIGER .ALPHA.-GALACTOSIDASE

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C97485

National Cancer Institute reference terminology for clinical and research data.

Substance Type

structurallyDiverse

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

NCBI Taxonomy

5061

Unique numeric identifier used to specify biological species in the NCBI database.

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Aspergillus Niger .alpha.-galactosidase. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.